Site updated at Wednesday, 22 June 2016

Living with Dementia

Amyloid Targeting Treatment

Beta secretase inhibitors to treat Alzheimer’s disease

With each new amyloid-targeting treatment for Alzheimer’s disease that has been developed, there has been a corresponding concern. For example, antibodies targeting amyloid-β peptide (Aβ) produce inflammation in the brain in some patients. Gamma secretase inhibitors tend to produce adverse effects by interacting with Notch, an important pathway for cellular signaling.

Beta secretase 1… Beta secretase inhibitors to treat Alzheimer’s disease   

Living With Dementia

syndrome of dementia1 - dementia patients8 - parkinsons5 - elder care1 - statins1 - mci7 - symptoms of parkinson's3 - alpha-synuclein proteins1 - early signs of dementia1 - earliest stages of alzheimers disease1 - chronic traumatic encephalopathy1 - phosphodiester1 - sleep loss1 - imbecility1 - transdermal rivastigmine1 - adam101 - alzheimer sufferer1 - declines in memory1 - hspb11 - great mimicker1 - als1 - spect1 - dementia community1 - prostate cancer1 - amyvid2 - foolishness1 - korsakoff syndrome3 - anticholinergics1 - dementia cases2 - wernicke’s encephalopathy1 -